Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Infectious Dx Firm Vision Medicals Completes $29M Series B Financing Round

NEW YORK – Chinese infectious disease startup Visions Medical said on Thursday it recently closed a Series B financing round that raised RMB200 million ($28.8 million).

The round was led by CDH Investments with contributions from CICC Capital, the Guangzhou-based firm said. So far, Visions Medical has raised nearly $50 million, including a $14 million Series A round last year. 

The company said the funds will be used for research and development to improve its infectious disease diagnostics; to build a national clinical laboratory network to reduce testing turnaround time; to seek regulatory approval for its clinical metagenomic assays for pathogen detection; and to strengthen its marketing and sales network. Vision Medicals has also been developing a CRISPR-based diagnostic test for tuberculosis to be used at the point of care.  

In March the firm received CE-IVD marking for its SARS-CoV-2 Clinical Sequencing assay, which uses next-generation sequencing. It also published a preprint earlier this year on a CRISPR-based SARS-CoV-2 diagnostic test, which is different from the CE-marked test. 

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.